Dhanushka Munkanatta Godage
About Dhanushka Munkanatta Godage
Dhanushka Munkanatta Godage is a Postdoctoral Associate at the Broad Institute of MIT and Harvard, specializing in the development of bifunctional molecules and CRISPR/Cas9 genome editing. He holds a PhD in Biochemistry from Wayne State University and has a strong publication record in notable scientific journals.
Work at Broad Institute
Dhanushka Munkanatta Godage has been serving as a Postdoctoral Associate at the Broad Institute of MIT and Harvard since 2019. In this role, he focuses on the development of bifunctional molecules, including PROTAC and PHICS, which are essential for proximity-directed protein modifications. His work involves developing assays for in vitro and cell-based screening of small molecule libraries aimed at identifying inhibitors of CRISPR nucleases. The Broad Institute, located at 415 Main St, Cambridge, MA, is renowned for its contributions to biomedical research and genomics.
Education and Expertise
Dhanushka Munkanatta Godage holds a Bachelor of Science degree in Pharmacy from the University of Colombo, where he studied from 2006 to 2010. He further advanced his education by obtaining a Doctor of Philosophy in Biochemistry from Wayne State University, completing his studies from 2013 to 2018. His academic background has equipped him with expertise in CRISPR/Cas9 genome editing, high-throughput screening techniques, and mammalian cell culture.
Previous Experience at Dana-Farber Cancer Institute
Before joining the Broad Institute, Dhanushka Munkanatta Godage worked as a Postdoctoral Associate at Dana-Farber Cancer Institute for a brief period in 2018 to 2019. This role contributed to his experience in cancer research and further developed his skills in molecular biology techniques. Dana-Farber is recognized for its focus on cancer treatment and research, providing a strong foundation for his subsequent work.
Research Specialization
Dhanushka Munkanatta Godage specializes in the development of bifunctional molecules, particularly PROTAC and PHICS. These molecules play a significant role in proximity-directed protein modifications, which are crucial for advancing therapeutic strategies. His research also includes developing assays for the screening of small molecule libraries to identify inhibitors of CRISPR nucleases, showcasing his proficiency in cutting-edge genomic technologies.
Publication Record
Dhanushka Munkanatta Godage has established a strong publication record, with articles featured in reputable journals such as the Journal of the American Chemical Society (JACS) and Nature Communications. His contributions to the scientific community reflect his commitment to advancing knowledge in the fields of biochemistry and molecular biology.